FriedenIJHaggstromANDroletBA. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol. 2005;22:383-406.
2.
HassaneinAHMullikenJBFishmanSJGreeneAK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg. 2011;127:347-351.
3.
FlorsLLeiva-SalinasCMagedIM. MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics. 2011;31:1321-1340.
4.
HaggstromANDroletBABaselgaE. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006;118:882-887.
5.
FinnMCGlowackiJMullikenJB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18:894-900.
6.
TakahashiKMullikenJBKozakewichHPRogersRAFolkmanJEzekowitzRA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93:2357-2364.
7.
KellyM. Kasabach-Merritt phenomenon. Pediatr Clin North Am. 2010;57:1085-1089.
8.
WalterJWBleiFAndersonJLOrlowSJSpeerMCMarchukDA. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet. 1999;82:77-83.
9.
HarteminkDAChiuYEDroletBAKerschnerJE. PHACES syndrome: a review. Int J Pediatr Otorhinolaryngol. 2009;73:181-187.
10.
DroletBAFrommeltPCChamlinSL. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128-140.
